✦ LIBER ✦

Open study on the efficacy and safety of long-term use of SURGAM-SR (sustained-release form of tiaprofenic acid) in rheumatoid arthritis patients

✍ Scribed by W. Kean; W. Buchanan; J. P. Pelletier; B. Haraoui; D. Choquette; J. L. Senecal; J. Gascon; G. Germain; H. Menard; S. Huang; R. Elie; E. Gerecz-Simon

Book ID: 110611197
Publisher: Springer
Year: 1993
Tongue: English
Weight: 450 KB
Volume: 2
Category: Article
ISSN: 0925-4692
DOI: 10.1007/bf02663742

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of OM-8980 in patien

Efficacy and safety of OM-8980 in patients with rheumatoid arthritis: an open-label, long-term, multicenter study

✍ Klaus Bandilla 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 763 KB

Long-term open-label preliminary study o

Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis

✍ Earl Silverman; Lynn Spiegel; David Hawkins; Ross Petty; Donald Goldsmith; Laura 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

Open-label extension study on the long-t

Open-label extension study on the long-term efficacy, safety, and impact on quality of life of OROS® hydromorphone extended release in patients with chronic low back pain

✍ M. Wallace; J. Thipphawong 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Long-term efficacy and safety of etanerc

Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open-label, extended-treatment trial

✍ Daniel J. Lovell; Edward H. Giannini; Andreas Reiff; Olcay Y. Jones; Rayfel Schn 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

Open-Label Study on the Long-Term Effica

Open-Label Study on the Long-Term Efficacy, Safety, and Impact on Quality of Life of OROS Hydromorphone ER in Patients with Chronic Low Back Pain

✍ Mark Wallace; John Thipphawong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

Phase III, multicenter, open-label, long

Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic disease-modifying antirheumatic drugs

✍ Takeuchi, Tsutomu; Matsubara, Tsukasa; Urata, Yukitomo; Suematsu, Eiichi; Ohta, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 250 KB